Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PreviDent 5000 Booster Plus is a prescription-only, high-fluoride home fluoride therapy toothpaste developed by Colgate Oral Pharmaceuticals, a subsidiary of Colgate-Palmolive. Its active ingredient is 1.1% sodium fluoride (5,000 ppm), formulated with FluoriGard technology and tricalcium phosphate to promote remineralization and increase enamel resistance to acid dissolution. It is indicated for the prevention and treatment of dental caries (tooth decay), particularly in patients at high risk for caries, and has been shown to help reduce white spot enamel lesions. It is used once daily in place of regular toothpaste.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PreviDent 5000 Booster Plus.